Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Top Cited Papers
- 27 January 2021
- journal article
- research article
- Published by Elsevier BV in Cell Host & Microbe
- Vol. 29 (3), 477-488.e4
- https://doi.org/10.1016/j.chom.2021.01.014
Abstract
No abstract availableKeywords
Funding Information
- Defense Advanced Research Projects Agency (HR001117S0019)
- National Institutes of Health (R37 AI059371, R01 AI157155, 75N93019C00062, R01 AI127828)
- Saint Louis University
This publication has 38 references indexed in Scilit:
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronavirusesNature Microbiology, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Broadly protective human antibodies that target the active site of influenza virus neuraminidaseScience, 2019
- Mapping the Evolutionary Potential of RNA VirusesCell Host & Microbe, 2018
- Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication FidelityPLoS Pathogens, 2013
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential TherapeuticsPLoS Pathogens, 2013
- Viral Quasispecies EvolutionMicrobiology and Molecular Biology Reviews, 2012
- Viral Mutation RatesJournal of Virology, 2010